Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $14.7 million.

  • Jaguar Health's Total Non-Current Liabilities rose 4556.08% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year increase of 4556.08%. This contributed to the annual value of $9.1 million for FY2024, which is 3908.73% down from last year.
  • Per Jaguar Health's latest filing, its Total Non-Current Liabilities stood at $14.7 million for Q3 2025, which was up 4556.08% from $12.6 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Total Non-Current Liabilities ranged from a high of $44.8 million in Q1 2022 and a low of $9.1 million during Q4 2024
  • Its 5-year average for Total Non-Current Liabilities is $24.7 million, with a median of $14.9 million in 2023.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first surged by 12086.88% in 2021, then plummeted by 6357.49% in 2023.
  • Jaguar Health's Total Non-Current Liabilities (Quarter) stood at $41.4 million in 2021, then dropped by 1.07% to $41.0 million in 2022, then plummeted by 63.57% to $14.9 million in 2023, then tumbled by 39.09% to $9.1 million in 2024, then surged by 61.61% to $14.7 million in 2025.
  • Its last three reported values are $14.7 million in Q3 2025, $12.6 million for Q2 2025, and $11.1 million during Q1 2025.